HYPOPHOSPHATAEMIC OSTEOMALACIA

This adverse event was reported 264 times

These drugs are most commonly taken by patients reporting HYPOPHOSPHATAEMIC OSTEOMALACIA:

# Drug Count
0 ADEFOVIR DIPIVOXIL 59
1 TENOFOVIR DISOPROXIL FUMARATE 39
2 LAMIVUDINE 25
3 LAMIVUDINE ORAL 25
4 TENOFOVIR DISOPROXIL FUMARATE TABLETS 23
5 ANTACID 18
6 CALCIUM CARBONATE 18
7 ZOLEDRONIC ACID 17
8 LANSOPRAZOLE 15
9 VALPROIC ACID 11
See all common drugs associated with HYPOPHOSPHATAEMIC OSTEOMALACIA

HYPOPHOSPHATAEMIC OSTEOMALACIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ADEFOVIR DIPIVOXIL 59 0.0464
1 IBANDRONATE SODIUM 10 0.0032
2 TENOFOVIR DISOPROXIL FUMARATE TABLETS 23 0.0027
3 FERRIC CARBOXYMALTOSE 6 0.0013
4 LAMIVUDINE 25 0.0010
5 LEVOCARNITINE 3 0.0008
6 ENTECAVIR 9 0.0008
7 IRON SUCROSE 6 0.0006
8 ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE 4 0.0006
9 ALBENDAZOLE 1 0.0005
See all drugs enriched for association with HYPOPHOSPHATAEMIC OSTEOMALACIA